You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME/CE

Guidelines Issued for Nutritional Options for Early Life May Affect Development of Atopic Disease

  • Authors: News Author: Laurie Barclay, MD
    CME Author: Charles Vega, MD
  • CME/CE Released: 1/8/2008
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 2/10/2010
Start Activity


Target Audience and Goal Statement

This article is intended for primary care clinicians, obstetricians, pulmonary medicine specialists, allergists, and other specialists who care for children at risk of developing atopic disease.

The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.

Upon completion of this activity, participants will be able to:

  1. Describe trends in the prevalence of atopic disease in childhood.
  2. Identify dietary interventions that can have an impact on the incidence of atopic disease in childhood.


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Laurie Barclay, MD

    Laurie Barclay, MD, is a freelance reviewer and writer for Medscape.

    Disclosures

    Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.

Editor(s)

  • Brande Nicole Martin

    Brande Nicole Martin is the News CME editor for Medscape Medical News.

    Disclosures

    Disclosure: Brande Nicole Martin has disclosed no relevant financial information.

CME Author(s)

  • Charles P Vega, MD

    Associate Professor; Residency Director, Department of Family Medicine, University of California, Irvine

    Disclosures

    Disclosure: Charles Vega, MD, has disclosed an advisor/consultant relationship to Novartis, Inc.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should only claim credit commensurate with the extent of their participation in the activity. Medscape Medical News has been reviewed and is acceptable for up to 350 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 09/01/08. Term of approval is for 1 year from this date. This activity is approved for 0.25 Prescribed credits. Credit may be claimed for 1 year from the date of this activity.

    Note: Total credit is subject to change based on topic selection and article length.


    AAFP Accreditation Questions

    Contact This Provider

    For Nurses

  • This Activity is sponsored by Medscape Continuing Education Provider Unit.

    Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; None of these credits is in the area of pharmacology.

    Provider Number: 6FDKKC-PRV-05

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape encourages you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CME/CE

Guidelines Issued for Nutritional Options for Early Life May Affect Development of Atopic Disease

Authors: News Author: Laurie Barclay, MD CME Author: Charles Vega, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME/CE Released: 1/8/2008

Valid for credit through: 2/10/2010

processing....

January 8, 2008 — The American Academy of Pediatrics (AAP) has issued an updated policy statement that reviews the nutritional options during pregnancy, lactation, and the first year of life that may or may not affect the development of atopic disease. The new recommendations, which discuss the role of maternal dietary restriction, breast-feeding, timing of introduction of complementary foods, and hydrolyzed formulas, are published in the January issue of Pediatrics.

"This clinical report reviews the nutritional options during pregnancy, lactation, and the first year of life that may affect the development of atopic disease (atopic dermatitis, asthma, food allergy) in early life," write Frank R. Greer, MD, and colleagues from the AAP Committee on Nutrition and Section on Allergy and Immunology. "It replaces an earlier policy statement from the American Academy of Pediatrics that addressed the use of hypoallergenic infant formulas and included provisional recommendations for dietary management for the prevention of atopic disease. The documented benefits of nutritional intervention that may prevent or delay the onset of atopic disease are largely limited to infants at high risk of developing allergy (ie, infants with at least 1 first-degree relative [parent or sibling] with allergic disease)."

The evidence reviewed does not support a major role for maternal dietary restrictions during pregnancy or lactation. However, breast-feeding for at least 4 months vs feeding formula made with intact cow's milk protein seems to prevent or delay development of atopic dermatitis, cow's milk allergy, and wheezing in early childhood.

Studies of infants who are at high risk for atopy and who are not exclusively breast-fed for 4 to 6 months offer modest evidence suggesting that use of hydrolyzed formulas may delay or prevent the onset of atopic disease vs formula made with intact cow's milk protein. This especially seems to be the case for atopic dermatitis. However, not all hydrolyzed formulas protect to the same extent, based on comparative studies.

"There is also little evidence that delaying the timing of the introduction of complementary foods beyond 4 to 6 months of age prevents the occurrence of atopic disease," the study authors write. "At present, there are insufficient data to document a protective effect of any dietary intervention beyond 4 to 6 months of age for the development of atopic disease." The study authors then summarize, "It is evident that inadequate study design and/or a paucity of data currently limit the ability to draw firm conclusions about certain aspects of atopy prevention through dietary interventions."

Bearing in mind these limitations, the study authors make the following recommendations:

  • Currently, there is no evidence that maternal dietary restrictions during pregnancy play a significant role in preventing atopic disease in infants. Except possibly for atopic eczema, avoidance of antigens during lactation does not seem to prevent atopic disease, although available data are scanty at best.
  • For infants at high risk for development of atopic disease, available evidence supports that exclusive breast-feeding for at least 4 months vs feeding intact cow's milk protein formula decreases the cumulative incidence of atopic dermatitis and cow's milk allergy in the infant's first 2 years of life.
  • Available evidence supports that exclusive breast-feeding for at least 3 months protects against wheezing in the child's early life, but in infants at risk of developing atopic disease, available evidence is not convincing that exclusive breast-feeding protects against allergic asthma in children after 6 years of age.
  • Based on studies of infants at high risk of developing atopic disease who are not breast-fed exclusively for 4 to 6 months or who are formula fed, evidence is modest that use of extensively or partially hydrolyzed formulas vs cow's milk formula may delay or prevent early childhood atopic dermatitis. Not all hydrolyzed formulas have the same protective benefit; extensively hydrolyzed formulas may help prevent atopic disease to a greater extent than partially hydrolyzed formulas.
  • More studies are needed to elucidate whether these benefits persist into late childhood and adolescence. Any decision-making process regarding use of hydrolyzed formulas must consider their higher cost. Use of amino acid–based formulas to prevent atopy has not yet been studied.
  • To date, no convincing evidence supports the use of soy-based infant formula to prevent allergy.
  • Solid foods should not be introduced before the infant is 4 to 6 months old. However, evidence to date is unconvincing that delaying their introduction beyond that time frame significantly helps prevent the development of atopic disease, regardless of whether infants are fed cow's milk protein formula or human milk. This recommendation also applies to foods thought to be highly allergic, such as fish, eggs, and foods containing peanut protein.
  • In infants 4 to 6 months of age, data are insufficient to support a protective effect of any dietary intervention for the development of atopic disease.

"Additional studies are needed to document the long-term effect of dietary interventions in infancy to prevent atopic disease, especially in children older than 4 years and in adults," the study authors conclude. "This document describes means to prevent or delay atopic diseases through dietary changes. For a child who has developed an atopic disease that may be precipitated or exacerbated by ingested proteins (via human milk, infant formula, or specific complementary foods), treatment may require specific identification and restriction of causal food proteins."

Pediatrics. 2008;121:183-191.

Clinical Context

Although the increased prevalence of asthma among children in the United States has been well documented, there is evidence that these illnesses are becoming more common in other parts of the world as well. A study of Austrian children by Schernhammer and colleagues, which was published in the December 14, 2007, issue of Pediatric Allergy and Immunology, compared rates of atopic disease among children between 1995 and 2003. Among children between the ages of 6 to 7 years, there was evidence of an interval increase in the prevalence of physician-diagnosed asthma (+16%), hay fever (+22%), and eczema (+37%). The respective increases in prevalence of these illnesses among children between the ages of 12 and 14 years were 32%, 19%, and 28%.

Nutrition has been implicated as 1 possible reason for the general rise in the prevalence of atopic disease among children. The current clinical report summarizes the scientific evidence and recommendations regarding this issue.

Study Highlights

  • There is not enough evidence to recommend dietary restrictions among pregnant women with the goal of reducing atopic disease in their children. Although dietary food allergens can be detected in breast milk, there is insufficient evidence to recommend exclusion diets among lactating mothers.
  • Breast-feeding for 3 months has been demonstrated to reduce the risk for incident atopic dermatitis among children by 32% vs formula feeding. This effect is most prominent among children with a family history of allergy. The authors recommend exclusive breast-feeding for at least 4 months to reduce the risk for atopic dermatitis in their children.
  • Exclusive breast-feeding for at least the first 4 months of the infant's life can also reduce the risk for incident cow's milk allergy during the first 2 years of childhood.
  • Exclusive breast-feeding during infancy may actually increase the risk of developing asthma, particularly among children with a family history of asthma. Conversely, breast-feeding may reduce the frequency of wheezing episodes among children younger than 4 years.
  • There is no evidence that hydrolyzed formulas are superior to human milk in preventing atopic disease.
  • Hydrolyzed formulas may delay or prevent atopic dermatitis vs cow's milk formula, but not all hydrolyzed formulas provide the same degree of benefit. In particular, extensively hydrolyzed formulas may be beneficial in this outcome.
  • Soy formulas should not be recommended for the prevention of atopic disease. Amino acid–based formulas have not been extensively studied in the prevention of atopic disease.
  • Previous research suggested that delaying the introduction of solid foods can reduce the risk for atopic disease, but more recent, methodologically sound trials have not been supportive of the delayed introduction of complementary foods. The current report recommends that solid foods not be introduced before the infant is 4 to 6 months old, but there is insufficient evidence to recommend further delay in the introduction of complementary foods, regardless of whether infants are fed formula or human milk. Also, there is insufficient evidence to recommend the withholding of foods considered to be highly allergenic, including fish, eggs, and foods containing peanut protein.
  • No significant data support any dietary intervention for infants 4 to 6 months old to prevent atopic disease.
  • More research is necessary to study the long-term effects of early dietary interventions to prevent atopic disease during later childhood and adulthood.

Pearls for Practice

  • Previous research has suggested that the prevalence of asthma, eczema, and hay fever has increased among younger and older children.
  • The current clinical report suggests that breast-feeding during the first 4 months of life reduces the risk for atopic dermatitis vs alimentation with cow's milk formula. However, many other dietary interventions during early life do not seem to have a profound effect in reducing the risk for atopic disease.

CME/CE Test

  • Print